FDA.reportPublic FDA data

Acyclovir

Product NDC
71335-1077
11-digit product format
713351077
Labeler code
71335
Product ID
71335-1077_1e1ab04a-ed67-4b12-a671-92b86ac9153e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Acyclovir
Dosage form
TABLET
Route
ORAL
Labeler
Bryant Ranch Prepack
Application
ANDA210401
Marketing category
ANDA
Marketing start
2018-05-04
Marketing end
0000-00-00
Substance
ACYCLOVIR
Active strength
400 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
71335-1077-071335107700120 TABLET in 1 BOTTLE (71335-1077-0) 120 tablet2019-02-080000-00-00NoNoCurrent
71335-1077-17133510770120 TABLET in 1 BOTTLE (71335-1077-1) 20 tablet2019-08-280000-00-00NoNoCurrent
71335-1077-27133510770228 TABLET in 1 BOTTLE (71335-1077-2) 28 tablet2019-03-120000-00-00NoNoCurrent
71335-1077-37133510770330 TABLET in 1 BOTTLE (71335-1077-3) 30 tablet2019-01-280000-00-00NoNoCurrent
71335-1077-47133510770450 TABLET in 1 BOTTLE (71335-1077-4) 50 tablet2022-02-140000-00-00NoNoCurrent
71335-1077-57133510770515 TABLET in 1 BOTTLE (71335-1077-5) 15 tablet2022-02-140000-00-00NoNoCurrent
71335-1077-67133510770660 TABLET in 1 BOTTLE (71335-1077-6) 60 tablet2019-11-070000-00-00NoNoCurrent
71335-1077-77133510770725 TABLET in 1 BOTTLE (71335-1077-7) 25 tablet2019-03-220000-00-00NoNoCurrent
71335-1077-87133510770810 TABLET in 1 BOTTLE (71335-1077-8) 10 tablet2022-02-140000-00-00NoNoCurrent
71335-1077-97133510770940 TABLET in 1 BOTTLE (71335-1077-9) 40 tablet2019-03-190000-00-00NoNoCurrent